Schedule of Segments (Tables)

3 Months Ended

Mar. 31, 2017

Schedule of Segments (Tables)

Schedule of Segment Reporting Information, by Segment

The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below.

		Cannabis and Medical Marijuana Segment		Legacy Investment		Corporate and Eliminations		Consolidated
Three months ended March 2017
Net sales	$	-	$	738,144	$	-	$	738,144
Income before taxes		(299)		23,592		(464,509)		(441,216)
Interest income		-		1		28,293		28,294
Interest expense		-		5,184		(1,134)		4,050
Total assets		1,148,992		1,116,210		5,511,704		7,776,906
Property additions		-		-		-		-
Depreciation and amortization		-		3,323		625		3,948
Three months ended March 2016
Net sales		450		642,844		-		643,294
Income before taxes		4,094		20,745		(213,983)		(189,144)
Interest income		2,694		-		24,553		27,247
Interest expense		-		4,316		7,552		11,868
Total assets		1,607,772		1,123,451		1,575,690		4,306,913
Property additions		-		5,268		1,029		6,297
Depreciation and amortization		1,568		30,004		(25,634)		5,938